OOIR: Observatory of International Research

Papers

(The H4-Index of JAMA Neurology is 75. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Diplopia and Ptosis in an Older Woman	480
Somebody to Love	475
Optimizing the Time Course of Risks and Benefits of Acute Dual Antiplatelet Therapy for Stroke Prevention	462
Early Posttraumatic Seizures—Putting Things in Perspective	368
A Call to Action to Address Sex Differences in Alzheimer Disease Clinical Trials	361
Equipping AI for Unbiased and Inclusive Neurology	228
Itching Frequency and Neuroanatomic Correlates in Frontotemporal Lobar Degeneration	227
Error in Author Name	222
Automated Imaging Differentiation for Parkinsonism	218
Origin of Transthyretin in Cerebral Amyloid Angiopathy	212
Ghrelin for Neuroprotection in Post–Cardiac Arrest Coma	209
Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation	204
Association of Disease-Modifying Treatment and Anti-CD20 Infusion Timing With Humoral Response to 2 SARS-CoV-2 Vaccines in Patients With Multiple Sclerosis	204
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation	204
Early Access to First-Seizure Clinics, Subsequent Outcomes, and Factors Associated With Attendance	204
Risk of Dementia in Individuals With Emergency Department Visits or Hospitalizations Due to Cannabis	199
Substantia Nigra Pathology, Contact Sports Play, and Parkinsonism in Chronic Traumatic Encephalopathy	189
Association Between Increased Seizures During Rewarming After Hypothermia for Neonatal Hypoxic Ischemic Encephalopathy and Abnormal Neurodevelopmental Outcomes at 2-Year Follow-up	187
Rizatriptan vs Placebo for Attacks of Vestibular Migraine	173
Alternate Hemibody Hyperkinetic and Hypokinetic Movement Disorders Due to Strategic Lesions in Cerebral Toxoplasmosis	172
Magnetic Resonance Imaging Features of Tropical Candidal Meningoencephalitis	171
Reinterpreting Clinical Trials in Children With Multiple Sclerosis Using a Bayesian Approach	154
JAMA Neurology	152
JAMA Neurology	151
Is It Really Itching?	150

The Neurologist’s Imperative in Brain Death	146
Anticoagulation and Antiplatelet Therapy in Patients With Atrial Fibrillation and Atherosclerosis	144
Teleneurorehabilitation and Motor and Nonmotor Symptoms and Quality of Life in Parkinson Disease	139
Thrombolysis With Tenecteplase for Minor Disabling Stroke	137
External Carotid Artery Angioplasty Based on Ultrahigh-Resolution Photon-Counting CTA	136
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis	134
Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease	130
Time to Change the Current Clinical Classification of Multiple Sclerosis?	130
Functional Outcomes in Conservatively vs Surgically Treated Cerebellar Infarcts	129
Time From Hospital Arrival Until Endovascular Thrombectomy and Patient-Reported Outcomes in Acute Ischemic Stroke	124
Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation	119
Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers	116
N-Acetylcysteine for Hereditary Cystatin C Amyloid Angiopathy	115
Do Neurologists Need a Goldwater Rule?	111
Error in Abstract	111
Disentangling Workflow Paradigms and Treatment Decision-making in Acute Ischemic Stroke	105
Error in Figure	101
Histologic Anatomy of Neurocysticercosis	101
Error in Additional Contributions	100
Error in Figure	97
Spontaneous AICA Dissection Presenting With Isolated Audiovestibular Loss	97
Functional Seizures—A Critical Comorbidity Overlooked in Epilepsy Research—Reply	97
Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease	96
Sleep Recording for the Diagnosis and Treatment of Paraplegia	95
Is It Really Itching?—Reply	95
Association of Cardiovascular Events With Spouse’s Subsequent Dementia	95
Spinal Cerebrospinal Fluid Leak Mimicking a Cerebellopontine Angle Tumor	94
β-Amyloid Positron Emission Tomography Use Across Medicare Administrative Contractor Regions	93
JAMA Neurology	93
Seizure Frequency Trends Over Time in Treatment-Resistant Focal Epilepsy	91
Visual Neglect After an Isolated Lesion of the Superior Colliculus	91
Intra-Arterial Tenecteplase After Successful Reperfusion in Large Vessel Occlusion Stroke	89
Retinal Hemorrhage Associated with Human Granulocytic Anaplasmosis	89
Prourokinase vs Standard Care for Patients With Mild Ischemic Stroke	88
Tackling the Unmet Therapeutic Needs in Nonsurgical Treatments for Epilepsy	87
Contribution of Somatic Ras/Raf/Mitogen-Activated Protein Kinase Variants in the Hippocampus in Drug-Resistant Mesial Temporal Lobe Epilepsy	86
Risk Factors Associated With Late-Onset Epilepsy in Dementia and Mild Cognitive Impairment	84
Endovascular Stroke Thrombectomy for Patients With Large Ischemic Core	84
Noncontrast Computed Tomography vs Computed Tomography Perfusion or Magnetic Resonance Imaging Selection in Late Presentation of Stroke With Large-Vessel Occlusion	84
Role of the X Chromosome in Alzheimer Disease Genetics	82
Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy in Neurology	82
Interhemispheric Bullet Migration—A Surgical Dilemma	82
GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias	82
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum	81
JAMA Neurology	78
Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease	78
JAMA Neurology	76
Error in Text	76
Acute Myelopathy in a Man With Cutaneous Papules	75
Perceived CTE and Suicidality—Is Perception Reality?	75